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Renal tubular epithelial cells express osteonectin in vivo and in vitro.
Osteonectin (SPARC, culture shock protein, BM-40) is a widely dis-
tributed glycoprotein which binds calcium and several extracellular
matrix proteins, including interstitial collagens and thrombospondin,
but whose physiologic role remains undefined. In the present studies,
we have demonstrated that immunoreactive osteonectin is present in
the distal cortical tubule and medullary tubules of murine kidney. We
surveyed the renal epithelial cell lines LLC-PK1, MDCK, and OK for
the expression of mRNA encoding osteonectin. We found that os-
teonectin mRNA is expressed by LLC-PK1 and OK cells but not by
MDCK cells, as well as by adult kidney from several species. Calcitonin
and vasopressin, agents which increase cAMP in these cells, were
found to decrease steady-state osteonectin mRNA concentrations. We
found that LLC-PK1 cells produced osteonectin protein, that the
protein was localized to intracellular granules, and that the protein
bound hydroxyapatite in vitro. Pulse-chase analysis revealed that
osteonectin was secreted from the cell layer to the medium after a lag
time of four to six hours and was secreted preferentially from the
basolateral domain of the cell. The preferential secretion of the calcium-
binding protein osteonectin from the renal epithelial cell is consistent
with several possible functions, including a structural extracellular
matrix protein, a participant in transepithelial ion transport, and an
inhibitor of extracellular calcification.
Osteonectin (SPARC, culture shock protein, BM-40) is a
calcium-binding phosphoprotein initially described as a compo-
nent of mineralized tissues [1]. Osteonectin is a glycoprotein
with an apparent molecular weight (Mr) of approximately 45 kD
which is present in a variety of embryonic and adult tissues. In
general, osteonectin is expressed in adult rodents and humans
in four groups of tissues: 1) matrix producing tissues, including
osteoblasts, endometrium, and decidua; 2) corticosteroid-se-
creting tissues, including adrenal cortex, ovary, and testis
(Leydig cells); 3) epithelial cells in salivary gland, lactating
mammary gland, jejunum, testis (Sertoli cells), and renal tu-
bule; and 4) platelets [2—6]. Some cell types express osteonectin
in vitro, although they do not express the protein constitutively
in vivo; these include bovine aortic endothelial cells [7] and
fibroblasts derived from a variety of sources, including dermis
and tendon [8].
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Another secreted phosphoprotein, osteopontin (SPP- 1, PP69,
bone sialoprotein-I, 2ar), is also distributed among many tis-
sues. Osteopontin is a sialic acid-containing protein with Mr 44
to 69 kD which was originally isolated from rat long bone [9]. In
vivo, osteopontin is localized to certain osteoblasts and osteo-
cytes, renal epithelial cells, neurons, sensory and secretory
cells of the inner ear, and the decidua and placenta [10].
Osteopontin is present within apical endocytic vacuoles and
lysozomes in the proximal renal epithelial cell, and this has
been interpreted as serum-derived osteopontin undergoing up-
take and degradation [11]. However, osteopontin mRNA has
subsequently been demonstrated by in situ hybridization in
both proximal and distal tubules and loops of Henle, indicating
endogenous expression at these sites [12]. In vitro, osteopontin
is expressed by both mesenchymal cells (ROS 17/2.8 and Swiss
3T3) and epithelial cells (mouse JB6 C122 epidermal cells)
[12—14].
While carrying out an immunohistochemical survey of the
tissue distribution of osteonectin in the adult mouse, we noted
abundant immunoreactive osteonectin in the renal tubular epi-
thelial cell. To determine whether osteonectin associated with
renal epithelial cells is due to circulating osteonectin filtered at
the glomerulus or to local synthesis, we examined several
established renal epithelial cell lines. We found that osteonectin
mRNA was expressed by LLC-PK1 and OK cells. In the
LLC-PK1 cell, osteonectin protein was localized to intracellular
granules, and was secreted preferentially from the basolateral
domain of the cell. A somewhat different distribution was found
for osteopontin, with mRNA expression in LLC-PK1 and
MDCK cells.
Methods
Immunohistochemistry
Kidneys from two 45-day-old C57 mice were fixed for two
hours at 4°C in 4% buffered formaldehyde (freshly made from
paraformaldehyde) and embedded in paraffin. A rabbit antise-
rum directed against a peptide sequence representing amino
acid residues 1-16 of murine osteonectin (SPARC), provided by
Dr. L. W. Fisher, NIDR, NIH, was used for immunohisto-
chemistry using a standard immunoperoxidase protocol. The
antiserum gave optimal results at a dilution of 1:100 in PBS with
0.1% BSA. The second antibody was a peroxidase-labelled goat
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anti-rabbit IgG used at a dilution of 1:80. The sections were
counterstained with hematoxylin. Controls included the omis-
sion of the first antiserum and an antigen absorption test. This
was done by incubating the working dilution of the antiserum
with 1 nanomole of the antigen, with subsequent use of the
antigen-absorbed antiserum in the immunohistochemical stain.
Cell culture
LLC-PK1 cells (CL 101, passage 196), MDCK cells (CCL 34,
passage 49), and OK cells (CRL 1840, passage 33) were
obtained from American Type Culture Collection (Rockville,
Maryland, USA); these renal epithelial cell lines are derived
from pig, dog, and opossum, respectively. All cell lines were
maintained in DMEM and F12K (Biofluids, Rockville, Mary-
land, USA), mixed 1:1, and experiments were performed within
ten passages. Both media contained 4500 mg/liter glucose and
were supplemented with penicillin, streptomycin, and 10%
heat-inactivated fetal bovine serum (Gibco, Grand Island, New
York, USA). Fetal human bone cells were prepared and main-
tained as previously described [15, 16]. Cells were passaged
with 0.05% trypsin in 10 mri EDTA (Biofluids). In certain
experiments, cells were plated on 0.45 pm pore size polycar-
bonate filters precoated with collagen type I and suspended in
35 mm tissue culture wells (Costar, Cambridge, Massachusetts,
USA). In other experiments, the following agents were used:
human calcitonin (Bachem, Torrance, California, USA), argi-
nine vasopressin (Bachem), human parathyroid hormone (1-34)
(Sigma Chemical Co., St. Louis, Missouri, USA), human
parathyroid hormone-related protein (1-40) (Bachem), dibutyryl
cAMP (Sigma), nifedipine (Sigma) and the calcium ionophore
A32187 (Sigma). The peptides and dibutyryl cAMP were dis-
solved in sterile distilled water. Nifedipine and A23 187 were
dissolved in dimethylsulfoxide, and for experiments using these
agents, an equivalent amount of dimethylsulfoxide (final con-
centration 0.1%) was used as a control.
Isolation of total RNA and Northern blotting
Confluent monolayers of renal epithelial cells growing in 150
mm plastic tissue culture plates were harvested with 4 M
guanidine isothiocyanate containing 0.12 M /3-mercaptoethanol
and ultracentrifuged through a cesium chloride cushion [17].
The pellet was resuspended in 0.1 M sodium acetate, pH 6.0,
extracted with buffered phenol, extracted with chloroform:
isoamyl alcohol (24:1), and precipitated twice with ethanol.
Kidney tissue was snap frozen in liquid nitrogen and stored at
—70° until further processing. The tissues were homogenized in
4 M guanidine, 0.3 M sodium acetate using a tissue homogenizer
(Tekmar, Cincinnati, Ohio, USA). Samples were extracted with
phenollchloroform/isoamyl alcohol, and the supernatants were
twice precipitated with ethanol at —20°C. The concentration of
total RNA was determined by measuring the absorbance at 260
nm, and the purity of the RNA preparation was confirmed by
demonstrating an absorbance 260:280 ratio of >1.6.
For Northern blotting, 10 pg of total RNA were electro-
phoresed through 1% agarose-formaldehyde gels. The gels were
stained with ethidium bromide and photographed under UV
light using Type 57 film (Polaroid, Cambridge, Massachusetts,
USA). The RNA samples were transferred to nitrocellulose
filters and fixed by irradiation at 120 millijoules delivered by a
UV crosslinker (Strategene, La Jolla, California, USA). A 1.5
kb partial-length human osteopontin cDNA [18], a 2.4 kb
partial-length human osteonectin cDNA [191, and a 2.0 kb
full-length cDNA encoding human J3-actin [20] were radiola-
belled using [32P]deoxyCTP (New England Nuclear, Dupont,
Boston, Massachusetts, USA) using the random primer method
according to the manufacturer's instructions (Amersham, Ar-
lington Heights, Illinois, USA). Hybridization was carried out
at 37°C in a mixture of 50% formamide, 0.1 g/ml dextran sulfate,
5 x SSC (74 m sodium citrate, 750 m sodium chloride), 10
mM Tris (pH 7.5), 4x Denhardt's solution (lx = 2% Ficoll, 2%
polyvinylpyrrolidine) and 0.1 mg/ml denatured salmon sperm
DNA. The filters were washed under stringent conditions at
68°C three times for 15 minutes each in 0.2x SSC and 0.1%
SDS. Autoradiographic exposures were made at —70°C using
Kodak X-AR film (Eastman Kodak, Rochester, New York,
USA). The density of the visible bands was quantitated using a
flying spot densitometer (Shimadzu, Japan); two exposures of
different duration were quantitated to confirm that the density
response of the film was in the linear range.
Indirect immunofluorescence
LLC-PK1 cells were plated at a density of 50,000 cells per
cm2 on glass slides with affixed wells (Nunc, Naperville,
Illinois, USA). At confluence, cell layers were washed gently
with PBS three times and fixed in methanol at —20°C for one
hour. After further washes with PBS, the slides were incubated
for 20 minutes with blocking antibody (normal goat serum
diluted 1:5 in PBS) and then incubated for 60 minutes with
specific antiserum or control serum diluted 1:40 in PBS. The
specific antiserum used was a polyclonal rabbit antiserum
(designated BON) raised against a preparation of bovine Os-
teonectin which was purified from bone as previously described
[2]. This antiserum displays broad species cross-reactivity.
After five washes with PBS lasting a total of 60 minutes, the
slides were incubated for 20 minutes with FITC-labelled goat
anti-rabbit IgG (Kirkegaard and Perry, Rockville, Maryland,
USA), diluted 1:20 in PBS. After further washes with PBS, a
coverslip was mounted with glycerol and the slide examined
with an Olympus microscope equipped with epifluorescence
optics. Cells incubated with specific antiserum or control serum
were photographed using T-Max 400 film (Eastman Kodak)
exposed for equivalent duration.
Metabolic labelling and immunoprecipitation
Cells in confluent monolayer culture were placed in DMEMI
P12K medium deficient in leucine and proline and supple-
mented with 10% dialyzed heat-inactivated fetal bovine serum
(Gibco) and 50 sg/m1 ascorbic acid. [14C]leucine (5 Ci/ml,
New England Nuclear) and ['4C}proline (5 sCilml, New En-
gland Nuclear) were added to the medium. After a 15-minute
labelling period, the medium and cell layer samples were
harvested separately (pulse sample). Cell layers were washed
twice and fresh medium containing leucine and proline was
added. At various time points up to 24 hours, medium and cell
layers were harvested separately (chase samples). Medium and
cell layer specimens were transferred to immunoprecipitation
buffer (final concentration 0.1% SDS, 1% Triton X-lOO, 1%
deoxycholate, and 1% aprotinin). Immunoprecipitation was
performed using anti-bovine osteonectin antiserum (BON) and
4 to 20% SDS-polyacrylamide gels (SDS-PAGE) as described
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previously [15], except that protein G Sepharose (Genex,
Rockville, Maryland, USA) was used. The intensity of the
autoradiographic bands was quantitated by densitometry as
described above.
To investigate polarized secretion, cells were grown on
porous polycarbonate filters suspended in tissue culture wells.
When the cells reached confluence as judged by phase contrast
microscopy, the cells were washed with and placed in medium
deficient in leucine and proline. ['4C]leucine and ['4C]proline
were added to the lower compartment of the multi-wells, which
was chosen because uncharged amino acids are selectively
transported into the LLC-PK1 cell from the basolateral domain
[211. For the pulse-chase samples, the labelling medium was left
in place for one hour, after which apical and basal media were
removed separately. The inserts and wells were washed with
DMEM/FI2K medium containing unlabelled leucine and pro-
line and supplemented with 10% fetal bovine serum, and fresh
medium was added. At 2, 6, and 24 hours, the medium and cell
layers were harvested separately. For the steady-state label
sample, medium supplemented with [14C]leucine and [14C]pro-
line was left on the cells for 24 hours, after which medium and
cell layer sample were harvested. Immunoprecipitation was
performed as described above.
Hydroxyapatite binding
Hydroxyapatite, from Dr. D. Eanes, NIDR, NIH, was pre-
pared in solution at acidic pH and room temperature, using a
pH-stat to bring the pH to 7.4 and maintain this pH for 24 hours
with continuous stirring. Examination of this preparation using
x-ray crystallography revealed the lattice structure typical of
hydroxyapatite. Further, the preparation had a smaller crystal
size compared to commercial preparations of hydroxyapatite,
which provides a substantially higher surface area. Ten micro-
grams of hydroxyapatite in a microfuge tube were washed three
times with 1.0 ml of 4 s guanidine, 0.05 M Tris, pH 7.4 (G
buffer). The hydroxyapatite pellet was then resuspended in 0.9
ml of G buffer, and 0.1 ml of radiolabelled conditioned medium
was added. After shaking for three hours at 25°C, the tubes
were centrifuged for 10 minutes and the supernatant removed
(G fraction). The pellets were washed twice with G buffer and
the washes combined with the G fraction. The pellet was
resuspended in 0.5 M EDTA, 0.05 M Tris, pH 7.4, gently shaken
for 20 minutes, and centrifuged. The supernatant was removed
(E fraction) and the process repeated, with the supernatant
added to the E fraction, until there was no visible pellet
remaining. The G and E fractions were then exchanged into 4 M
urea using a Centricon ultrafiltration device with a molecular
exclusion limit of 10 kD. Sample recovery under these condi-
tions was approximately 60%. The samples were boiled for 10
minutes at 100°C in the presence of 25 mi dithiothreitol, and
subjected to SDS-PAGE. The gels were processed for fluorog-
raphy. In some experiments samples were exchanged into
immunoprecipitation buffer and immunoprecipitation per-
formed as described above.
Statistics
Analysis of variance was calculated using the Kruskal-Wallis
test. P values <0.05 were considered statistically significant.
Results
Immunolocalization of osteonectin
Immunohistochemical staining of adult murine kidney was
performed with an antiserum directed against an amino terminal
peptide of munne osteonectin fragment. Positive staining was
detected within epithelial cells of the distal cortical tubules, but
not within the proximal tubules or glomeruli (Fig. 1A, C, and
D), and within epithelial cells lining nearly all medullary tu-
bules, representing both collecting tubules and Henle's loops
(Fig. lB). In the presence of osteonectin peptide, no staining
was observed, confirming antibody specificity (data not shown).
Osteonectin gene expression in cultured renal cells
A survey of several well-characterized renal epitheial cell
lines was undertaken to investigate whether mRNAs encoding
osteonectin and osteopontin were expressed by these cells in
vitro. Northern analysis using a human osteonectin eDNA
revealed that fetal human bone cells, LLC-PK1 cells, and OK
cells but not MDCK cells express osteonectin mRNA (Fig. 2).
The osteonectin cDNA probe used in these studies has previ-
ously been shown to hybridize with canine material [22], and
therefore osteonectin mRNA expression by MDCK cells,
which are of canine origin, can be excluded. Human bone cells
expressed two osteonectin mRNA transcripts, approximately
2.2 and 3.0 kb in size, with the smaller species predominating,
while LLC-PK1 and OK cells expressed only the smaller
transcript. (In Figure 2, the osteonectin mRNA species from
OK cells is slightly retarded in mobility compared to the lower
transcript in fetal bone cells; this is an artifact, as can be seen by
examination of the ethidium bromide-stained gel, which dem-
onstrates that the ribosomal RNA was similarly retarded.)
These findings are in accord with the transcript sizes reported in
human fetal tissues, in which bone has two osteonectin tran-
scripts (2.2 and 3.0 kb) and kidney has only the smaller
transcript [19, 23]. Recent evidence suggests that the two
transcripts expressed in human cells share identical coding
regions, with the longer transcript having additional 3' untrans-
lated sequence [24]. Northern analysis using an osteopontin
cDNA probe revealed that LLC-PK1 and MDCK cells express
mRNA for osteopontin. The osteopontin mRNA is approxi-
mately 1.1 to 1.2 kb in size (Fig. 2), which is similar to that
previously reported [18, 25]. OK cells did not express osteo-
pontin mRNA (Fig. 2). While cross-hybridization of the osteo-
pontin cDNA probe with opossum mRNA has not been estab-
lished, it is likely to do so, as this probe hybridizes with rat,
bovine, and human material [18]. Fetal human bone cells at an
early phase of cultural maturation, and in the absence of
supplemental 1 ,25-dihdroxyvitamin D3, also did not express
osteopontin mRNA (Fig. 2). In this regard, rat osteosarcoma
cells respond to 1 ,25-dihydroxyvitamin D3 by increasing osteo-
pontin expression [13].
Osteonectin gene expression in adult kidney
While the osteonectin gene is known to be expressed in fetal
kidney, we wished to determine whether the osteonectin gene is
transcribed in the fully mature kidney. Northern analysis was
performed using kidney tissue obtained from mouse (3 weeks),
monkey (29 years), and a human patient (age 61 years, nephrec-
tomy for adenocarcinoma and the normal portions of the kidney
;A B .S1. ci)U. iZIc
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Fig. 1. Localization of immunoreactive osteonectin in adult mouse kidney. Formaldehyde-fixed, paraffin-embedded tissue was stained with
anti-mouse osteonectin peptide antiserum and peroxidase-labelled second antibody, and counterstained with hematoxylin. Within the cortex,
immunoreactive osteonectin was found in the distal tubule and was absent from the glomerulus and proximal tubule (A, C, D). Within the medulla,
immunoreactive osteonectin was present in most tubules (B). Original magnification, x 100 (A, B) and x815 (C, D).
processed). As shown in Figure 3, all mammalian kidneys
examined expressed osteonectin mRNA, with mouse express-
ing one transcript size and monkey and human tissue expressing
two transcript sizes. In monkey, comparable levels of osteonec-
tin mRNA is present in cortex and medulla.
Hormonal regulation of osteonectin mRNA
We investigated whether peptide factors or agents which alter
intracellular calcium regulate expression of osteonectin mRNA
in LLC-PK1 cells. Total RNA was prepared from LLC-PK1
cells in monolayer culture treated with various agents for 24
hours. Samples from duplicate dishes were subjected to North-
ern analysis, and the ratio of osteonectin mRNA to control
mRNA, /3-actin, was estimated by densitometry. As shown in
Figure 4, treatment with 10 flM calcitonin or 100 flM arginine
vasopressin, agents known to increase cAMP in LLC-PK1
cells, resulted in a 41 1% and 36 13% decrease in steady
state concentrations of osteonectin mRNA, normalized to /3-ac-
tin mRNA (mean SD of 4 samples from 2 independent
experiments, P < 0.05). Under the same conditions 100 M
dibutyryl cAMP had no effect, suggesting that the effect of
calcitonin and vasopressin on the accumulation of osteonectin
mRNA is not mediated by an increase in intracellular cAMP.
Ten micromolar parathyroid hormone (1-34) and 10 JiM para-
thyroid hormone-related protein (1-40) had no significant effect
on expression of osteonectin mRNA. Likewise, agents which
alter trans-membrane calcium transport, the calcium ionophore
A23187 (0.5 JiM) and the calcium channel antagonist nifedipine
(1 LM), and exposure to medium with a reduced total calcium
concentration (0.3 m compared to normal 1.3 mM) had no
quantitative effect on osteonectin mRNA expression.
Osteonectin secretion
To determine whether the osteonectin mRNA expressed by
LLC-PK1 cells is translated into protein, cells in monolayer
culture were metabolically labelled with ['4C]leucine and
['4C]proline. Immunoprecipitation with anti-bovine bone Os-
teonectin antiserum revealed a polypeptide with an Mr of
approximately 45 kD. Pulse-chase analysis was employed to
determine the kinetics of osteonectin secretion (Fig. 5). Cell
layer osteonectin activity appeared at the end of the 15-minute
pulse period and reached a maximum after 30 minutes of chase.
Immunoreactive osteonectin appeared in the medium by one
hour following the pulse and reached a maximum at two hours.
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Fig. 3. Osteonectin mRNA expression in adult kidney. Total RNA was
prepared from LLC-PK1 cells, FVB/N mouse whole kidney, rhesus
monkey renal cortex and medulla, and human renal cortex. Northern
analysis was performed using a radiolabelled human osteonectin
eDNA. The positions of 28s and 18s ribosomal RNA are shown on the
right, and the positions of the two osteonectin mRNAs are indicated by
arrowheads.
Fig. 2. Expression of osteopontin and osteonectin mRNA by cultured
human bone cells and renal epithelial cell lines. Ten micrograms of total
RNA from fetal human bone cells, LLC-PK1, MDCK and OK cells
were electrophoresed through an agarose-formaldehyde gel, and
stained with ethidium bromide (A). The samples were transferred to
nitrocellulose, and probed with a human osteopontin cDNA (B), or a
human osteonectin cDNA (C). The positions of 28 Sand 18 S ribosomal
RNA are indicated. Autoradiographic exposures were made at 70°C for
24 hours (osteopontin, OP), and 14 hours (osteonectin, ON).
There was a subsequent decline in cell layer osteonectin, and a
second peak at 24 hours. As expected from the Northern
analysis, immunoprecipitation of medium and cell layers from
MDCK cells revealed no immunoreactive osteonectin (data not
shown),
Localization of osteonectin in cultured renal cells
The subcellular location of osteonectin in LLC-PK1 cells was
examined by indirect immunofluorescence using anti-osteonec-
Fig. 4. LLC-PK1 expression qf osteonectin mRNA in response to
calcitonin and vasopressin. LLC-PK1 cells in monolayer culture were
exposed to vehicle control, 10 TIM calcitonin, or 100 flM arginine
vasopressin for 24 hours. Duplicate samples from two independent
experiment were subjected to Northern analysis using cDNA probes for
osteonectin and /3-actin, and the autoradiograms were quantitated by
densitometry, The ratio of osteonectin mRNA:/3-actin mRNA, normal-
ized to control, mean SD (N = 4). (*) denotes significantly different
from control, P < 0.03.
tin antiserum. In these cells, immunoreactive osteonectin was
distributed in a punctate pattern, most prominent in a pen-
nuclear location (Fig. 6). These cytoplasmic vesicular struc-
tures may represent endocytic, lysozomal, or secretory vesi-
des. Similar localization has been shown in cultured
osteoblasts [261,
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B
Fig. 5. Kinetics of osteonectin secretion by
LLC-PK1 cells. LLC-PK1 cells in monolayer
culture were pulse labelled for 15 minutes
with ['4C]leucine and {'4C]proline, and fresh
medium containing unlabelled leucine and
proline were added. Medium and cell layer
samples were harvested after the pulse (P)
and after various durations of chase (0.25, 0.5,
1, 2, 4, 10, 12, and 24 hr), and
immunoprecipitated with anti-bovine
osteonectin antibody. The position of
osteonectin is indicated by an arrow.
Fig. 6. Localization of osteonectin in LLC-
PK1 cells. LLC-PK1 cells in monolayer
culture were fixed with methanol and
examined with indirect immunofluorescent
technique using an anti-bovine osteonectin
antiserum. Immunoreactive osteonectin was
distributed in the cytoplasm in a punctate
pattern. Original magnification, 200 x.
Osteonectin binding to hydroxyapatite
Osteonectin purified from bone is known to bind both calcium
and hydroxyapatite with high affinity. To learn whether the
immunoreactive osteonectin produced by LLC-PK1 cells also
binds hydroxyapatite, we tested the ability of radiolabelled
proteins synthesized by LLC-PK1 cells to bind synthetic hy-
droxyapatite. Since osteonectin has previously been shown to
bind to other proteins which bind calcium (such as thrombo-
spondin), the binding assay was performed in 4 M guanidine
buffer to disrupt supermolecular aggregates. Serial washes to
remove protein not bound to hydroxyapatite were pooled (G
fraction), and the hydroxyapatite pellet was dissolved in 0.5 M
EDTA (E fraction). The E fraction, representing hydroxyapa-
tite-bound proteins synthesized by LLC-PK1 cells, included at
least five distinct protein species (Fig. 7A). When the G and E
fractions were immunoprecipitated and analyzed by SDS-
PAGE and fluorography, it was demonstrated that osteonectin
was one of the molecular species present in the E fraction and
was absent from the G fraction. This indicated that all immu-
noreactive osteonectin was bound to hydroxyapatite (Fig. 7B).
Polarized secretion of osteonectin
Since some but not all proteins secreted by cultured renal
epithelial cells are secreted in a polarized fashion, we investi-
gated possible polarized secretion of osteonectin. For these
studies, LLC-PK1 cell cultures were established on porous
polycarbonate inserts suspended in multi-well plates. Under
these conditions, epithelial cells are exposed to medium from
both apical and basal surfaces and are believed to maintain a
more physiologic phenotype when compared to cells in mono-
layer culture [271. LLC-PK1 cells were metabolically pulse-
labelled by adding [14C]leucine and ['4C]proline for one hour to
the basal medium, followed by a chase in medium supple-
mented with unlabelled leucine and proline. The apical media,
basal media, and cell layers were harvested separately, and
immunoprecipitation was performed using an anti-bovine os-
teonectin antibody (Fig. 8). The kinetics of osteonectin secre-
tion were investigated by harvesting media and cell layers
immediately after the pulse and again after 2, 6, and 24 hours of
chase. Most immunoreactive osteonectin left the cell layer by
six hours and entered the medium. At all time points tested,
—200—
—97—
—46—
P0.250.51 2 4 101224 P0.250.51 24 101224
Cell layer Medium
Total G EB Total 
i-ON
Fig. 7. Hydroxyapatite binding of osteonectin synthesized by LLC-
PK, cells. Conditioned medium from LLC-PK1 cells metabolically
labelled with ['4C}leucine and ['4C]proline was added to a synthetic
hydroxyapatite pellet in 4 M guanidine buffer. After three washes with
guanidine buffer to remove the unbound proteins (G fractions), the
pellet was solubilized in 0.5 M EDTA buffer to release the bound
proteins (E fraction). An aliquot of these fractions were subjected to
SDS-PAGE (panel A), and the remainder of the fractions were immu-
noprecipitated with anti-bovine osteonectin antiserum and subjected to
SDS-PAGE (panel B). The position of osteonectin (ON) is indicated.
more osteonectin was present in the basal medium than in the
apical medium. In the same experiment, cells were metaboli-
cally labelled for 24 hours and samples harvested as above (Fig.
8, lanes "SS"). After 24 hours of steady state labelling, the
amounts of immunoprecipitable material in each fraction is
quantitated by densitometry of submaximally exposed autora-
diograms were as follows: 18% in the cell layer, 28% in the
apical medium, and 54% in the basal medium.
Discussion
In the present study, we have demonstrated the presence of
osteonectin protein in murine kidney, localized to the cortical
distal tubule and to collecting ducts and loops of Henle.
Osteonectin is a protein whose physiologic function remains to
be defined. It has a high affinity for calcium (Kd 80 flM) [28],
probably due to its high content of acidic amino acid residues
and/or to E-F hand structures predicted from sequence analysis
[291. In a solid phase assay, osteonectin accelerates hydroxy-
apatite deposition [2], while in a liquid phase assay it inhibits
the rate of hydroxyapatite crystal-seeded growth [281. Os-
teonectin produced by cell-free translation possesses a signal
peptide sequence, consistent with it being a secreted protein
Apical Basal Cell layer
medium medium
Fig. 8. Polarized secretion of osteonectin by LLC-PK7 cells. LLC-PK1
cells were grown to confluence on permeable tissue culture well inserts
and metabolically labelled with ['4C]leucine and ['4C]proline either for
one hour, after which the pulse sample (P) was harvested, and followed
by chase with complete medium for 2, 6, and 24 hours or steady state
labelled for 24 hours (SS). The apical medium, basal medium, and cell
layers were harvested separately and immunoprecipitated using anti-
bovine osteonectin antiserum. The positions of molecular weight mark-
ers and osteonectin (ON) are indicated.
[31]. In vitro, osteonectin binds thrombospondin [32], the a!
chain of collagen type I [33], and collagens type III and V [30].
Recently, it has been reported that osteonectin decreases
spreading of cultured bovine aortic endothelial cells [30].
We compared the renal epithelial cell expression of osteonec-
tin with the expression of another secreted phosphoprotein,
osteopontin. Osteopontin contains an Arg-Gly-Asp-Ser se-
quence [25] and promotes matrix attachment by osteoblasts,
gingival fibroblasts, and epithelial-like cells in vitro [34, 35] and
possibly by osteoclasts in vivo [36]. While osteopontin may
bind hydroxyapatite by virtue of stretches of acidic amino acid
residues, we are unaware of published data concerning the
binding of osteopontin to calcium or hydroxyapatite. Exposure
of cells to serum, platelet-derived growth factor, or the protein
kinase C activator TPA, and transformation of cells with the
H-ras oncogene are all associated with an increase in osteopon-
tin gene expression [14, 37].
To demonstrate that osteonectin is a product of the renal
epithelial cells, we investigated established epithelial cell lines.
We found that LLC-PK1 and OK cells, but not MDCK cells,
expressed osteonectin mRNA. By comparison, LLC-PK1 and
MDCK cells, but not OK cells, expressed osteopontin mRNA.
The particular tubular origin of these cell lines has been
controversial, and this issue is complicated by the heterogene-
ity of these cell types and the likelihood of phenotypic shift in
response to cell culture conditions. Thus LLC-PK1 cells pos-
sess both proximal tubular markers (including the organic
cation transporter [38], the brush border enzymes alkaline
phosphatase and y-glutamyl transpeptidase, and receptors for
1 ,25-dihydroxyvitamin D3 [39]) and distal tubular markers (el-
evation of intracellular cAMP in response to calcitonin and
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vasopressin [40]). The expression of osteonectin and osteopon-
tin in certain cell lines may relate less to the presumed tubular
origin of the cells than to particular cell functions, which in turn
may derive from in vivo functions or alternatively may repre-
sent adaptation to culture conditions.
In kidney, the proximal tubule is quantitatively the dominant
site of calcium reabsorption, largely by passive mechanisms,
and is the dominant site of phosphate reabsorption, which is
accomplished by both active and passive mechanisms. Parathy-
roid hormone and possibly calcitonin inhibit phosphate reab-
sorption in this segment [41]. The distal convoluted tubule and
the collecting duct actively reabsorb calcium, and this is en-
hanced by parathyroid hormone [42]. Exposure of LLC-PK1
cells for 24 hours to calcitonin and arginine vasopressin, agents
for which these cells are known to have receptors, was associ-
ated with a modest but reproducible decrease in steady state
concentrations of osteonectin mRNA. This effect was not
reproduced with dibutyryl cAMP, suggesting that signalling
pathways other than adenylate cyclase are required for these
peptide factors to influence osteonectin mRNA expression. It
has not been determined whether this effect is due to a decrease
in transcription rate or a decrease in mRNA stability. The
physiologic significance of these findings are unclear. Calcitonin
increases calcium reabsorption from the loop of Henle, without
effect on the distal cortical tubule [43], and vasopressin is not
believed to modulate ion transport. Other factors which alter
renal calcium transport (parathyroid hormone and parathyroid
hormone-related protein) and agents which affect intracellular
calcium (the calcium ionophore A23 187, the calcium channel
blocker nifedipine, and exposure to low calcium medium) were
without quantitative effect on osteonectin mRNA expression.
Immunoprecipitation of medium and cell layers from meta-
bolically-labelled LLC-PK1 cultures using a specific anti-os-
teonectin antiserum established that these cells express os-
teonectin protein. The kinetics of osteonectin secretion, with
maximal accumulation in the medium by two hours, are similar
to the kinetics of osteonectin secretion displayed by porcine
and bovine bone cells [26, 441. In the present study, the total
amount of osteonectin, the sum of medium and cell layer
fractions, was not constant but rather fell with time, suggesting
that in this system osteonectin is rapidly degraded. Degradation
of osteonectin has been noted previously in cell culture models
[26, 45].
Renal epithelial cells exhibit a polarized phenotype, with an
apical domain facing the tubular lumen and a basolateral
domain facing the renal interstitium. Renal epithelial cells
secrete certain proteins in a polarized fashion. MDCK cells
preferentially secrete the glycoprotein complex gp8O from the
apical surface [46], and both MDCK cells [47] and LLC-PK1
cells (Kopp and G. Robey, unpublished data) preferentially
secrete the basement membrane constituents laminin and
heparan sulfate proteoglycan from the basolateral surface. The
function of osteonectin in the renal epithelial cell remains a
subject of speculation. The polarized secretion of osteonectin,
however, is consistent with several models. First, osteonectin
is a component of certain specialized extracellular matrices, as
has been suggested in mineralizing osteoid [2], human decidua
[5] and EHS sarcoma matrix [48]. The preferential secretion of
osteonectin from the basolateral domain of the LLC-PK1 cell
would be consistent with a structural function in the extracel-
lular matrix. Evidence against an extracellular matrix role for
osteonectin in the renal tubule includes the absence of immu-
nodetectable osteonectin within the interstitium and the tubular
basement membrane. Second, osteonectin may participate in
transepithelial ion transport. In this model, osteonectin would
serve as a calcium buffer acting within cytoplasmic vesicles
(endocytic vesicles and/or lysozomes) which are hypothesized
to transport calcium from the apical to the basolateral surface,
a process described in intestinal epithelial cells as transcaltachia
[49]. Our experiments show that factors which might alter
transcellular calcium transport in the LLC-PK1 cell, including
nifedipine, the calcium ionophore A23187, and altered medium,
calcium concentration, do not alter steady-state osteonectin
mRNA concentrations, at least over a 24 hour period. Thus, we
cannot offer evidence in support of this model. Third, osteonec-
tin, through its ability to inhibit hydroxyapatite crystal forma-
tion in solution phase, may serve to retard crystal deposition
within the kidney at sites of calcium transport. The demonstra-
tion of osteonectin expression by a renal epithelial cell line
provides a suitable system to examine the physiologic role of
osteonectin in epithelial tissues.
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